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Trish Greenhalgh is currently Dean for Research Impact at Barts and The London School of Medicine and
Dentistry. In discussion with Managing Editor Sierra Williams she delves into the nature of academic
impact and the remit of her appointment. She finds that many academics still have a naïve and
overly rationalistic view of how their work might link with policy. Drawing on the applied science of
telecommunications she also discusses an ‘ex ante’ approach where relevance is considered from
the research design phase. 
How are universities responding to the ‘impact agenda’ and how does this correspond with
how academics have approached impact-generating activity?
Impact has risen up the agenda because of the Research Excellence Framework (REF), and we’re all awaiting the
results of that exercise.  I don’t know of any university that doesn’t now have a named person with ‘impact’ on their
job description. But there is great variability in who takes on the impact portfolio. In some, it’s seen as a
‘communications’ issue. In others, it’s ‘entrepreneurship’ and in others ’training and development’. Of course, impact
is all these things and more. We need to be clear that impact isn’t a single dimension. Developing industry
partnerships, producing patents and generating spin-outs is a very different kind of activity from linking with local
communities or ensuring that the perspective of patients is taken account in the design of clinical trials.
Among the academic community there’s a spectrum of response – from whole-hearted enthusiasm for what some
people call ’third stream’ activities to equally deeply-held opposition. To some extent, it was ever thus. Back in 1939,
Abraham Flexner published a paper called ’The Usefulness of Useless Knowledge’ [pdf] arguing that the way to
generate socially useful innovations, especially in science, is to leave academics alone in their ivory towers to think
clever thoughts unencumbered by the worldly pressure to generate concrete benefits. The core of his argument was
that there is no simple, linear link between a particular piece of academic research and a downstream societal
benefit. As he put it, “Science, like the Mississippi, begins in a tiny rivulet in the distant forest. Gradually other
streams swell its volume. And the roaring river that bursts the dikes is formed from countless sources”.
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But even 100 years ago, there were academics who were externally facing and more interested in finding
applications for scientific discoveries than in contributing to building the academic knowledge base. The ‘Mode 1’
scientific discoveries of James Clark Maxwell (in the mathematics of magnetism and electricity) and Heinrich Hertz
(in electromagnetic waves) were of interest to Marconi because he saw their potential for informing the applied
science of telecommunications. Flexner was scathing in his dismissal of Marconi, who he described as an academic
of limited intellect who “picked other men’s brains”. But an alternative argument is that Marconi was a brilliant
applied scientist and an early protagonist of what we would now call ‘Mode 2 knowledge production’ – collaborative
interactions between academics and non-academics to generate knowledge that is useful to society.
How do you think the rhetoric on academic impact has changed over the past five years?
Rhetoric is the art of persuasion. I’m pleased to see lively debate continuing both within the academic community
and beyond it on the extent to which the work of university sector should be driven by society’s needs (and, some
say, by the vested interests of political and commercial stakeholders) as opposed to rising above these very needs
and interests to maintain the purity of the academic endeavour. I think what has changed is the growing perception
among critical academics that higher education has ‘sold its soul’ to (or, perhaps, had its soul stolen by) a powerful
alignment of industry and government that is wrongly conflating academic purpose with technological innovation
and wealth creation. That narrative sees the privileging of the STEM subjects and the starving of the arts and
humanities as a sinister by-product of the ‘impact’ agenda. But whilst I sympathise with those arguments, I think we
need to acknowledge how much positive benefit (economic and societal) has come from intersectoral collaborations,
facilitated by government, between industry and academia. We should also acknowledge the huge success of
applied research programmes funded by the National Institute of Health Research through multi-sector partnerships
between academics, NHS clinical services, patients and the public.
What are some of the big gaps that need to be addressed for how higher ed recognises the links between
research, policy and practice?
Many academics in the scientific disciplines have a naïve and overly rationalistic view of how their work might link
with policy. If they think about it at all, they assume a ‘knowledge-driven’ model of impact – that is, that their
discoveries will be impelled into practice and policy through their sheer innovative force when someone magically
places a copy of their clever paper on the desk of the relevant policymaker or industry magnate. This rarely
happens! Even Maxwell and Hertz needed the likes of Marconi to champion their discoveries and build the
relationships with real-world movers and shakers that were needed before concrete applications emerged. It has
been known for years that close and continuing relationships between academics and policymakers are the
cornerstone of getting research into policy. This isn’t a linear relationship where policy ‘receives’ the findings of
research. On the contrary, these relationships should be ‘ex ante’, informing the design of research to ensure that it
will be of relevance to policymakers. The evidence base on third stream activity by universities gives us many tips
on how better to package our academic outputs to make them accessible to non-academic partners, but it also
suggests that we still have much to learn about the science of ‘knowledge brokering’.
The medical sciences have for years contested blurred boundaries between research and industry (some
might say the negative sides of commercial collaboration) – what lessons have the community learned from
this?
I’ve addressed this question in a paper I published with colleagues recently. When I first became interested in
evidence-based medicine in the early 1990s, it was relatively easy to spot a research study (say, testing the efficacy
of a drug) that was contaminated by the vested interests of the drug’s own manufacturer. Today, the drug industry
(whose contribution to improving health and relieving suffering has been considerable) has penetrated academia –
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and academia has penetrated the drug industry – in a way that makes it much harder to identify truly unbiased
studies. We now have a situation in which almost all the major trials of drugs are funded by industry; many senior
academics have paid consultancies on the boards of such companies – and they also have leading roles in the
development of government policy and ‘evidence-based’ guidelines. All this interpenetration can be framed as
worthy ‘Mode 2’ connection-building, but questions also need to be asked about the feathering of personal nests by
industry backhanders.
You’ve also worked at the interface of different disciplines for years. Does interdisciplinary familiarity play a
role in developing broader impact?
Undoubtedly. Anyone who does interdisciplinary research knows it’s a conflict sport, since the definition of an
academic discipline is a field where we all share the same assumptions and engage in arguments about how to
build on those assumptions. Working with people outside our discipline means our collaborators don’t share our
assumptions, which means that progress at the beginning is much slower and intellectual conflict may be high. But
as most of us have discovered, that very intellectual conflict is often what produces new framings of a problem, new
theories and new empirical approaches – as well as exciting new findings that can revitalise a flagging field. The
same is true when we work in trans-disciplinary initiatives with non-academics, whose practical, experiential and
contingent knowledge of a shared field is complementary to our own theoretical and abstract knowledge. There is an
early phase of mutual frustration – but if this is properly managed through skilled facilitation, the outputs not only
generate innovative practical applications but also feed back to inform new avenues of academic inquiry. But when
this conflict is badly managed (and when some or all parties fail to see it as inherent to the process of trans-
disciplinary engagement), it becomes personalised and what began as exciting trans-disciplinary programmes can
end in acrimony.  If I were to identify a priority area of further study in research impact, it would be the governance
and facilitation of intersectoral projects and programmes.
Note: This article gives the views of the author, and not the position of the Impact of Social Science blog, nor of the
London School of Economics. Please review our Comments Policy if you have any concerns on posting a comment
below.
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